Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary extracted from

  • Hashemi, M.; Kordi-Tamandani, D.M.; Sharifi, N.; Moazeni-Roodi, A.; Kaykhaei, M.A.; Narouie, B.; Torkmanzehi, A.
    Serum paraoxonase and arylesterase activities in metabolic syndrome in Zahedan, southeast Iran (2011), Eur. J. Endocrinol., 164, 219-222.
    View publication on PubMed

Application

EC Number Application Comment Organism
3.1.1.2 medicine the lower enzyme activity in metabolic syndrome are considered an independent risk factor for cardiovascular disease Homo sapiens
3.1.8.1 medicine the lower enzyme activity in metabolic syndrome are considered an independent risk factor for cardiovascular disease Homo sapiens

Organism

EC Number Organism UniProt Comment Textmining
3.1.1.2 Homo sapiens
-
-
-
3.1.8.1 Homo sapiens
-
-
-

Source Tissue

EC Number Source Tissue Comment Organism Textmining
3.1.1.2 serum
-
 Homo sapiens
-
3.1.8.1 serum
-
 Homo sapiens
-

Substrates and Products (Substrate)

EC Number Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
3.1.1.2 phenyl acetate + H2O
-
 Homo sapiens phenol + acetate
-
 ?
3.1.8.1 paraoxon + H2O
-
 Homo sapiens 4-nitrophenol + diethyl phosphate
-
 ?

Expression

EC Number Organism Comment Expression
3.1.1.2 Homo sapiens serum arylesterase activity is significantly lower in patients with metabolic syndrome than healthy subjects down
3.1.8.1 Homo sapiens serum paraoxonase activity is significantly lower in patients with metabolic syndrome than healthy subjects down